Castle Biosciences Inc (CSTL) Stock Analysis

Castle Biosciences Inc (CSTL) is a publicly traded company in the HEALTHCARE sector. It trades at $19.71, carries a market capitalization of $636.02M. This page summarizes the public market data, fundamentals, and frequently asked questions for CSTL, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

• Price: $19.71
• Market Cap: $636.02M
• EPS: $-0.42
• 52-Week High: $44.28
• 52-Week Low: $14.59

Market Sentiment

Castle Biosciences Inc currently has a Neutral sentiment score of 0.04.

About Castle Biosciences Inc

None

GNG Research Analysis

GNG Research scores Castle Biosciences Inc (CSTL) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CSTL.

Frequently Asked Questions

Does CSTL pay dividends?

Castle Biosciences Inc (CSTL) does not currently pay a regular dividend.

What is CSTL's market cap?

Castle Biosciences Inc (CSTL) has a market capitalization of $636.02M with a current stock price of $19.71.